Elevation Oncology, Inc. ELEV 深 滬
已收盤 07-23 16:00:00 美东时间
0.365
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.365
- 總市值 2161.67万
- 52周最高 2.2599
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.221
- 委 比 0.00%
- 總股本 5922.37万
- 歷史最高 16.22
- 量 比 0
- 振 幅 0.00%
- 歷史最低 0.221
- 每 手 1
- 風險率 0.11%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多跨国药企洞察｜默沙东终止康方2亿美元合作项目，跨国药企如何“优中选优”？
（来源：动脉新医药） 编者按： 全球视野下的跨国药企深度洞察——创新、博弈与中国答卷 在全球医药产业发展的宏大叙事中，跨国药企始终扮演着关键角色——他们...
2025-08-12 08:02
Elevation Oncology Completes Merger with Concentra Biosciences
Elevation Oncology ( ($ELEV) ) has issued an update. Elevation Oncology, Inc. a...
2025-07-23 21:48
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KNW, ELEV, CRKN on Behalf of Shareholders
NEW YORK, June 12, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
2025-06-13 01:57
美股大行评级 | 潜在涨幅434.95%！VNRX获Jones Trading首予"买入"评级，目标价3美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1139478829918380033.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Guggenheim：维持Metsera(MTSR)"买入"评级，目标价从56美元升至62美元</p> <p>• 摩根大通：维持Avidity Biosciences(RNA)"超配"评级，目标价从57美元升至59美元</
2025-06-11 09:43
This McDonald's Analyst Turns Bearish; Here Are Top 4 Downgrades For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a comple...
2025-06-10 20:39
William Blair Downgrades Elevation Oncology to Market Perform
William Blair analyst Andy Hsieh downgrades Elevation Oncology (NASDAQ:ELEV) from Outperform to Market Perform.
2025-06-10 03:06
Elevation Oncology Merges with Concentra Biosciences
An update from Elevation Oncology ( ($ELEV) ) is now available. On June 8, 2025...
2025-06-09 20:29
50亿美元大单提前预告，石药集团有点着急？
炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 即将签下50亿美元大单，石药集团（1093.HK）股价随之上涨。 5月...
2025-06-03 23:39
Sarepta Therapeutics Shares Safety Results From ENDEAVOR Study In 2-Year-Old Participants
- Treatment with ELEVIDYS for Duchenne muscular dystrophy resulted in mean protein expression of 93.87% as measured by western blot in study participants (n=6)- Safety profile consistent with prior studies of ELEVIDYS
2025-05-16 21:06
Elevation Oncology shares are trading lower after the company reported worse-than-expected Q1 EPS results.
Elevation Oncology shares are trading lower after the company reported worse-th...
2025-05-15 22:41
